<p>The National Human Genome Research Institute awarded a purchase order to Keyence Corporation Of America for $161,199.00 on July 24, 2026, for a BZX fluorescence microscope. The order is firm fixed price with no set-aside applied. Place of performance is Elmwood Park, New Jersey. Ultimate completion is scheduled for July 23, 2027.</p>
The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded a $39,609 purchase order to Keyence Corporation of America for BZ-H3XD BZX software and a BZX multi-stack module, including a Dell T3420 PC. Keyence Corporation of America, a subsidiary of Keyence Corp., will deliver the requested products and perform the work at the specified place of performance in Bethesda, Maryland within the firm fixed price and...
<p>The National Human Genome Research Institute awarded a purchase order to Carl Zeiss Microscopy, LLC for $21,444.00 on May 13, 2019, with an ultimate completion date of July 31, 2020. Performance takes place in Thornwood, New York. The order carries firm fixed price terms and no set-aside designation. The source does not specify the nature of equipment or services procured under this purchase order.</p>
<p>The National Human Genome Research Institute awarded a purchase order to Carl Zeiss Microscopy, LLC valued at $20,004.00 on March 11, 2019. The order carries no set-aside designation. Performance location is Thornwood, New York. The period of performance runs from May 15, 2019 through May 14, 2020. No source material specifies the equipment or services procured under this order.</p>
<p>The National Human Genome Research Institute issued a purchase order to Life Technologies Corporation on July 20, 2020, valued at $24,773.44 for EVOS M5000 DSS with one year REX support. Place of performance is Grand Island, New York. The order carries a firm fixed price and has an ultimate completion date of September 30, 2020. No set-aside applies.</p>
<p>The National Human Genome Research Institute awarded a purchase order to Getinge USA Inc. for $12,285.00 on April 25, 2018, for supplies on a firm fixed price basis. No set-aside was used. Work is performed at Bethesda, Maryland. The order has an ultimate completion date of April 30, 2019.</p>
<p>The National Human Genome Research Institute awarded a purchase order to Beckman Coulter, Inc. valued at $6,243.00 on January 31, 2018, with ultimate completion on January 31, 2019.</p>
<p>The order is a firm fixed price purchase with no set-aside designation. Place of performance is Bethesda, Maryland. The source does not specify the goods or services being procured under this order.</p>
<p>The National Human Genome Research Institute (National Institutes of Health) awarded a purchase order to Illumina, Inc. valued at $208,735.16 on June 5, 2026, for firm fixed-price procurement with no set-aside designation. Work is performed in San Diego, California. The order is scheduled for ultimate completion by September 22, 2027.</p>
<p>The National Human Genome Research Institute awarded a purchase order to Fisher Scientific Company L.L.C. for $107,000 on August 7, 2018. The order procures a Cytation 5 imaging multi-mode system and BioSpa automated incubator for placement of performance in Bethesda, Maryland. The purchase order is a firm fixed price acquisition with an ultimate completion date of September 6, 2018.</p>
<p>The National Human Genome Research Institute awarded a purchase order to Omega Bio-Tek, Inc. valued at $9,180.00 on August 31, 2017. Performance is located in Bethesda, Maryland. The order carries a firm fixed price and ultimate completion date of September 4, 2018. No set-aside was applied.</p>